Last reviewed · How we verify
Isosorbid mononitrate
At a glance
| Generic name | Isosorbid mononitrate |
|---|---|
| Also known as | Isosorbide -5- mononitrate biphasic, Imdur |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial (PHASE4)
- Nitric Oxide Donors for Treatment of Isolated Oligohydramnios (PHASE2, PHASE3)
- Phytoestrogen, NO Donors, N-acetyl Cysteine Add Therapy to Clomiphene Citrate to Improve Pregnancy Rate in PCO Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isosorbid mononitrate CI brief — competitive landscape report
- Isosorbid mononitrate updates RSS · CI watch RSS
- Ain Shams University portfolio CI